Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
CEimpact Podcast - Negotiating High-Cost Drugs

Negotiating High-Cost Drugs

04/08/24 • 30 min

CEimpact Podcast

This episode discusses the 2023 Inflation Reduction Act and HHS's authority to negotiate prices for high-cost drugs in Medicare Part D. In addition to the initial list of 10 drugs, HHS is now focused on medications used in the hospital and covered under Medicare Part B.
The GameChanger
HHS updates the Inflation Reduction Act that will impact over 750, 000 people.
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad
Reference
Reduced Coinsurance for Certain Part B Rebatable Drugs Under the Medicare Prescription Drug Inflation Rebate Program

HHS Announces Savings for 41 Prescription Drugs Thanks to Inflation Rebates from the Biden-Harris Administration’s Lower Cost Prescription Drug Law

Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the monetary impact of the Inflation Reduction Act.
2. Discuss how the Medicare Part B drug addition will benefit patients.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-136-H04-P
Initial release date: 4/08/2024
Expiration date: 04/08/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

plus icon
bookmark

This episode discusses the 2023 Inflation Reduction Act and HHS's authority to negotiate prices for high-cost drugs in Medicare Part D. In addition to the initial list of 10 drugs, HHS is now focused on medications used in the hospital and covered under Medicare Part B.
The GameChanger
HHS updates the Inflation Reduction Act that will impact over 750, 000 people.
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad
Reference
Reduced Coinsurance for Certain Part B Rebatable Drugs Under the Medicare Prescription Drug Inflation Rebate Program

HHS Announces Savings for 41 Prescription Drugs Thanks to Inflation Rebates from the Biden-Harris Administration’s Lower Cost Prescription Drug Law

Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the monetary impact of the Inflation Reduction Act.
2. Discuss how the Medicare Part B drug addition will benefit patients.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-136-H04-P
Initial release date: 4/08/2024
Expiration date: 04/08/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Previous Episode

undefined - Quality in Healthcare

Quality in Healthcare

This episode discusses quality and value in healthcare and how the BPCI program, designed to lower costs and enhance care quality, particularly in the post-acute phase, did not demonstrate notable positive impacts on HF-related measures. What does this mean for the larger health quality landscape?
The GameChanger
Quality in healthcare is rapidly evolving. There are pressures at the population level that evaluate how we do things; the quality always needs to be safety focused.
Host
Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad
Reference
Article:
Bundled Payments for Care Improvement and Quality of Care and Outcomes in Heart Failure
https://jamanetwork.com/journals/jamacardiology/article-abstract/2813066
Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Define quality in healthcare.
2. Review outcomes of hospitals participating in the BPCI program.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-133-H04-P
Initial release date: 04/01/2024
Expiration date: 04/01/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Next Episode

undefined - Compounded GLP1s

Compounded GLP1s

Shortages, access, and cost have led to compounding GLP1s, which has created confusion and misinformation for patients and healthcare providers. Join us as we discuss this practice and delve into what you need to know as a healthcare provider.

THE GAMECHANGER: The advent of GLP1s is a true GameChanger in the health of patients with diabetes, cardiovascular diseases, and obesity, and has led to access issues for manufactured products.


Guests
Tenille Davis, PharmD, RPh

Chief Advocacy Officer
Alliance for Pharmacy Compounding

Scott Brunner, CAE
CEO
Alliance for Pharmacy Compounding
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Reference
https://a4pc.org/advocacy/educating-prescribers/

https://a4pc.org/advocacy/statements-and-other-resources/

https://a4pc.org/files/APC-Compounded-GLP-1s-Media-Brief-REVISED-March-2024.pdf


Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Review criteria for compounding drugs on the FDA drug shortage list.
2. Discuss the facts and misinformation surrounding compounded GLP1 medications.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-145-H01-P
Initial release date: 04/15/2024
Expiration date: 04/15/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

CEimpact Podcast - Negotiating High-Cost Drugs

Transcript

Speaker 1

Hey , ce Plan members from CE Impact , this is Game Changers . I'm Jen Moulton , and with me today I have not one , but both of our favorite contributors , doctors Jeff Wall and Jake Galdo . My job today is going to be moderating these two and keeping them on task and focus , so it's not a small job ,

Speaker 1

but it's my job today , so hel

Episode Comments

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/ceimpact-podcast-385948/negotiating-high-cost-drugs-54910823"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to negotiating high-cost drugs on goodpods" style="width: 225px" /> </a>

Copy